It's amazing how we are on the brink of LymPro revenues, and now people are suddenly starting to fear those revenues might be dismal. The company has stated all along that LymPro is on track as planned. Anyone can make revenue projections based on their analysis, the flip of a coin, or how many hairs they pull out of their nose on a given day.

Things aren't making sense because everyone is getting all wound up in unfounded speculations on a message board, and expecting Gerald to comment to alleviate their fears. If he doesn't nursemaid nervous shareholders, then automatically something is not right with the plan?

LymPro revenues won't be known until they are booked. I have no reason to believe Gerald has been hyping this as it is well documented there is a strong need for an AD diagnostic that is cheaper and more readily available than Amyvid. He isn't making this up, as some here seem to think.

I'm not unloading my position next week, next month, or next year. I'm committed to giving the company time to achieve revenue generation and won't be swayed by nervous investors who are looking for any reason to exit the stock. I know this will be a bumpy ride, but I believe the end goal will be worth the wait.

Anyone who can't tolerate the bumpy ride is certainly free to move investment dollars elsewhere. Mine are staying with this company.